Stay updated on NIB in TNBC Clinical Trial
Sign up to get notified when there's something new on the NIB in TNBC Clinical Trial page.

Latest updates to the NIB in TNBC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe webpage has been updated to include new collaborators, Merck Sharp & Dohme LLC and Celgene Corporation, and a new version revision number, v2.15.0. Additionally, the deletion of significant content regarding a phase II study on triple negative breast cancer has occurred, which may impact the understanding of the study's objectives and methodologies.SummaryDifference32%
- Check15 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check59 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check73 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.9%
- Check80 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to NIB in TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NIB in TNBC Clinical Trial page.